DSGN Competitors & Alternatives
Compare Design Therapeutics Inc with similar stocks in the same industry
Biotechnology
DSGN
Main Stock$14.37
Tradestie Score
55
Market Cap
$386.68M
Analyst Upside
+19.5%
Top Competitors
228 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
OCS
Oculis Holding AG Ordinary shares
|
$30.29
|
$910.64M | - | 58 | Compare |
|
BCAX
Bicara Therapeutics Inc. Common Stock
|
$20.23
|
$906.29M | - | 52 | Compare |
|
NBTX
Nanobiotix S.A. American Depositary Shares
|
$51.50
|
$903.54M | - | 58 | Compare |
|
ORKA
Oruka Therapeutics, Inc. Common Stock
|
$61.93
|
$900.91M | - | 53 | Compare |
|
GERN
Geron Corp
|
$1.29
|
$899.60M | - | 49 | Compare |
|
ANAB
AnaptysBio, Inc. Common Stock
|
$63.15
|
$894.30M | - | 60 | Compare |
|
ANL
ANL
|
$13.51
|
$892.56M | - | 53 | Compare |
|
EYPT
EyePoint Pharmaceuticals, Inc. Common Stock
|
$12.35
|
$890.20M | - | 58 | Compare |
|
TNGX
Tango Therapeutics, Inc.
|
$20.56
|
$887.30M | - | 55 | Compare |
|
ABUS
Arbutus Biopharma Corporation Common Stock
|
$4.24
|
$879.90M | 5.1 | 52 | Compare |
More DSGN Analysis
Data updated: May 18, 2026 | Industry: Biotechnology (SIC 2834)
228 stocks in this industry